Press Releases - 2022-01-10

Date	Title	Company
10-Jan-2022	Following Years of Record Growth, IL MAKIAGE Receives $130 Million Investment at $1.5 Billion Valuation	Businesswire
10-Jan-2022	Clarify Health Welcomes Niall Brennan as Chief Analytics and Privacy Officer	Businesswire
10-Jan-2022	Regulatory T-Cell Therapies Market by Target Indications, Key Players and Key Geographies - Global Industry Trends and Forecasts, 2021-2035 - ResearchAndMarkets.com	Businesswire
10-Jan-2022	Atara Biotherapeutics to Present Recent Progress and Key Upcoming Catalysts at the 40th Annual J.P. Morgan Healthcare Conference	Businesswire
10-Jan-2022	Large Volume Wearable Injectors Market by Type of Device, Usability, Therapeutic Area, Key Geographical Regions - Global Industry Trends and Forecasts, 2021-2035 - ResearchAndMarkets.com	Businesswire
10-Jan-2022	The Worldwide Blood Pressure Transducers Industry is Expected to Reach $1+ Billion by 2026 - ResearchAndMarkets.com	Businesswire
10-Jan-2022	Outlook on the Vegan Yogurt Global Market to 2026 - by Source, Flavor, Application, Distribution Channel and Region - ResearchAndMarkets.com	Businesswire
10-Jan-2022	Regulators Approve Impella 5.5 With SmartAssist in Japan and Hong Kong; US FDA Grants Impella BTR Conditional IDE Approval for First-in-Human Early Feasibility Study	Businesswire
10-Jan-2022	Halo Biosciences Participating in BIO @ JPM and BIOTECH SHOWCASE™ During J.P. Morgan Week 2022	Newswire
10-Jan-2022	QUANTA Dialysis Technologies Appoints Meghan Fitzgerald and Leslie Norwalk to Board of Directors	Businesswire
10-Jan-2022	Sole Source Capital Portfolio Company Peak Technologies Acquires Avalon Integration	Businesswire
10-Jan-2022	ReCode Therapeutics Appoints Shehnaaz Suliman, M.D., MBA, M.Phil., as Chief Executive Officer	Businesswire
10-Jan-2022	Peptilogics Announces FDA Clearance of Investigational New Drug Application to Initiate Clinical Trial of PLG0206 in Periprosthetic Joint Infection	Businesswire
10-Jan-2022	Bluestar Genomics Appoints David Mullarkey Chief Executive Officer	Businesswire
10-Jan-2022	H3 Biomedicine Welcomes Dr. Richard Woodman to its Board of Directors	Businesswire
10-Jan-2022	Vaxiion Therapeutics Announces Clearance of IND Application for the Intralesional Administration of VAX014 to Subjects with Treatment Refractory Solid Tumors	Businesswire
10-Jan-2022	ANJAC Health & Beauty joins forces with Canadian company APOLLO to expand its North American presence	Businesswire
10-Jan-2022	Published Paper Indicates Leronlimab Shows Activity Against 4-Class Drug Resistant HIV-1 From Heavily Treatment Experienced (“HTE") Subjects	Businesswire
10-Jan-2022	Equillium Announces Multiple Abstracts Accepted for Presentation at the Transplantation & Cellular Meetings of ASTCT and CIBMTR	Businesswire
10-Jan-2022	Affini-T Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference	Businesswire